karuna deal

Quote




















anonymous said:
Actually I am a DBL at another company and would never leave my job for a unapproved BID gamble, but you do you hotshot!
Click to expand...

ah coming back this time portraying a loser mgr which further validates your status of being shit canned from the process. Self redemption on here is the 1st place losers like you turn to deal with your rejection. Run along now son.
 












Damn quite sad. Lonely troll going manic late at nite posting irrelevant BS. A job like this won’t be for everybody. That’s ok! No need to post personal BS on here about your tainted 1 patient study opinions. The are lots of candidates that have legitimate interests in this new opportunity. Save the disgruntled personal opinions and hopefully the thread can have some value to those of us who are truly interested in the expansion.
 




anonymous said:
Damn quite sad. Lonely troll going manic late at nite posting irrelevant BS. A job like this won’t be for everybody. That’s ok! No need to post personal BS on here about your tainted 1 patient study opinions. The are lots of candidates that have legitimate interests in this new opportunity. Save the disgruntled personal opinions and hopefully the thread can have some value to those of us who are truly interested in the expansion.
Click to expand...
Actually I am a DBL at another company and would never leave my job for a unapproved BID gamble, but you do you hotshot!
 




anonymous said:
Damn quite sad. Lonely troll going manic late at nite posting irrelevant BS. A job like this won’t be for everybody. That’s ok! No need to post personal BS on here about your tainted 1 patient study opinions. The are lots of candidates that have legitimate interests in this new opportunity. Save the disgruntled personal opinions and hopefully the thread can have some value to those of us who are truly interested in the expansion.
Click to expand...

Don’t feed the troll!
 








anonymous said:
Damn quite sad. Lonely troll going manic late at nite posting irrelevant BS. A job like this won’t be for everybody. That’s ok! No need to post personal BS on here about your tainted 1 patient study opinions. The are lots of candidates that have legitimate interests in this new opportunity. Save the disgruntled personal opinions and hopefully the thread can have some value to those of us who are truly interested in the expansion.
Click to expand...
There is an old saying in pharma that being the 1st drug of a new class is better than being the best of the class. KarXT fits this category. They’ll be the only drug of a new class for the first couple of years before others hit. salaries will be very competitive to the market and you have 2 years to reap the benefits of a 1st in class new drug. In pharma nowadays 2 years is an eternity.
 




anonymous said:
Actually I am a DBL at another company and would never leave my job for a unapproved BID gamble, but you do you hotshot!
Click to expand...
Ok dumb fucking Alkermes manager… Stay on your piece of shit sinking ship. Hopefully you got a top secret raise, RSU’s or a pathetic promotion because we value you. Fucking take out the ball gag.

BMS made Abilify the #1 written drug in the world. I think we’ll be fine here. Can’t wait to resign to my clueless DBL.
 








anonymous said:
Ok dumb fucking Alkermes manager… Stay on your piece of shit sinking ship. Hopefully you got a top secret raise, RSU’s or a pathetic promotion because we value you. Fucking take out the ball gag.

BMS made Abilify the #1 written drug in the world. I think we’ll be fine here. Can’t wait to resign to my clueless DBL.
Click to expand...
Lighten up Luther! You aren’t fooling anyone with your tough guy talk
 




anonymous said:
There is an old saying in pharma that being the 1st drug of a new class is better than being the best of the class. KarXT fits this category. They’ll be the only drug of a new class for the first couple of years before others hit. salaries will be very competitive to the market and you have 2 years to reap the benefits of a 1st in class new drug. In pharma nowadays 2 years is an eternity.
Click to expand...
 




anonymous said:
Well for starters, I am doing my due diligence with feedback from your peers and previous colleagues. That information is at our fingertips, so please understand that there is knowledge of performance and work ethic long before you are even considered as an internal candidate. My recruiter provides some, but I am also reaching out to folks familiar with your current BMS standing. Great question though!
Click to expand...
Ain’t nobody getting hired here unless you are tightly connected to an RBM. Does not matter how strong a candidate or how qualified you are. These RBMs are all bringing in their own peeps from their previous companies. This is fact!
 




One of my hesitations is that this drug is BID especially in this space. I have my final interview coming up, can anyone give me any information about what the company is saying on how to approach this? I don’t see how providers who prescribe this if it’s BID when patients can’t even remember to adhere to taking an oral once a day. Thanks!
 




anonymous said:
One of my hesitations is that this drug is BID especially in this space. I have my final interview coming up, can anyone give me any information about what the company is saying on how to approach this? I don’t see how providers who prescribe this if it’s BID when patients can’t even remember to adhere to taking an oral once a day. Thanks!
Click to expand...
This medication is in an entirely new class by itself. Doctors tend to prescribe many drugs in the same class (polypharmacy) when symptoms aren't fully controlled. This would most likey be used as an add-on to first/second gen antipsychotics. Its not intended to replace the first line drugs. So the fact that its BID vs daily doesn't make a huge difference as its a second line agent.
 




Top Bottom
Back
Quote